Reuters Market Eye - Foreign institutional investors bought a net $495 million in Indian banks, while selling a net $791 million in pharmaceutical and biotechnology shares this month as of March 15, regulatory data shows.
As a result, lenders have been one of the top performers this month, during a month in which the Nifty has hit a slew of record highs, including most recently on Monday.
The NSE's bank sub index up about 15 percent so far this month, outperforming the nearly 5 percent gain in the Nifty.
For graphic: (http://link.reuters.com/wuc87v)
Analysts have attributed the strong interest in domestic oriented stocks such as banks on expectations the opposition Bharatiya Janata Party would win elections due next month given its perception as being more business-friendly.
Optimism about the domestic economy has also played a role, given easing inflation and a sharply narrower current account deficit.
(Reporting by Abhishek Vishnoi)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
